Gilead Sciences Inc. is planning to hire industry veteran Daniel O’Day to take the helm and help the drug company revive sales and recover from a disappointing deal, according to people familiar with the matter.

from MarketWatch.com - Top Stories https://ift.tt/2B8dVNg
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/2B8dVNg
via IFTTT
Kommentare
Kommentar veröffentlichen